isradipine, (s)-isomer has been researched along with itraconazole in 1 studies
Studies (isradipine, (s)-isomer) | Trials (isradipine, (s)-isomer) | Recent Studies (post-2010) (isradipine, (s)-isomer) | Studies (itraconazole) | Trials (itraconazole) | Recent Studies (post-2010) (itraconazole) |
---|---|---|---|---|---|
6 | 0 | 1 | 249 | 4 | 108 |
Protein | Taxonomy | isradipine, (s)-isomer (IC50) | itraconazole (IC50) |
---|---|---|---|
Tyrosine-protein kinase Fyn | Homo sapiens (human) | 3.89 | |
ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 0.7 | |
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 1.666 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.4256 | |
ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 0.2 | |
C-X-C chemokine receptor type 1 | Homo sapiens (human) | 2.5676 | |
Cruzipain | Trypanosoma cruzi | 3 | |
Vasopressin V2 receptor | Homo sapiens (human) | 3.476 | |
C-C chemokine receptor type 4 | Homo sapiens (human) | 3.2689 | |
Lanosterol 14-alpha demethylase | Homo sapiens (human) | 3.6 | |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
1 other study(ies) available for isradipine, (s)-isomer and itraconazole
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |